精确健康优化计划在高级帕金森病的管理:一个案例系列
G Niraj1, N Charan2, Shruti Niraj3
1Pain Medicine and Anesthesia, Sri Madhusudan Sai Institute of Medical Sciences and Research, Chikkaballapur, IND.
Cureus
|February 10, 2026
概括
一个新的精确健康计划改善了帕金森病 (PD) 患者的生活质量. 这种方法针对自主失衡,氧化应激和炎症,为管理高级PD提供了潜在的新途径.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 再生医学是一种再生医学.
背景情况:
- 帕金森病 (PD) 是一种快速增长的神经退行性疾病,对非运动症状和疾病修饰的治疗选择有限.
- 关键的病理特征包括线粒体功能障碍,氧化应激,神经炎症和α-synuclein聚合.
- 目前的治疗方法,如利沃多巴,主要是治疗运动症状,留下大量未满足的综合护理需求.
研究的目的:
- 评估一种新型的精确健康优化计划在患有晚期异常帕金森病的患者中的有效性.
- 评估该计划对疾病严重程度和生活质量的影响.
- 探索一种潜在的新疗法策略来改变PD的进展.
主要方法:
- 三名患有晚期异常性PD的患者接受了精确的健康计划.
- 干预措施包括双星状质块,营养药注射和体外血液臭氧治疗.
- 经验证的结果测量评估了在基线和12周的疾病严重程度和生活质量.
主要成果:
- 这三位患者都报告说帕金森病的严重程度有所降低.
- 患者在12周后,他们的生活质量有了显著的改善.
- 该计划成功地准了诸如自主失衡和氧化应激等潜在机制.
结论:
- 一个精确的健康优化计划在管理高级帕金森病方面表现有前途.
- 这种多模式的方法可能会提供超越当前症状治疗的好处.
- 需要对更大的队列和对照组进行进一步的研究来证实这些发现.
相关概念视频
01:15Parkinson's Disease: Overview
2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:22Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
01:27Peripheral Artery Disease III: Interprofessional Care
583
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
583
01:26Peripheral Artery Disease IV: Nursing Management
618
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
618